A Failsafe® suicide gene-based system to improve safety & standardization of neural grafts (Parish)

Dr. Ben Fryer, Co-Founder and CEO of Pluristyx, presented to webinar participants the “how and why” of integrating high quality ancillary raw materials into cell therapy product development and the manufacturing workflow, beginning with the starting cell source and MCB

The Universal Cell: Making the Unsafe Safe Andras Nagy, PhD, HonD, FRSC, Foreign Member of Hungarian Academy of Sciences; Shawn Kimel Research Scientist | Lunenfeld-Tanenbaum

Professor Clare Parish BBiomedSci, PhD; NHMRC Senior Research Fellow; Stem Cells and Neural Development laboratory; Florey Institute of Neuroscience & Mental Health; The University of